Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study

Klaus Kapelari1, Christine Kirchlechner, Wolfgang Högler

  • 1Department of Pediatric and Adolescent Medicine, Medical University of Innsbruck, Austria. klaus.kapelari@i-med.ac.at

BMC Endocrine Disorders
|November 28, 2008
PubMed

Insights

Pediatric thyroid hormone reference intervals for thyroid-stimulating hormone (TSH), free triiodothyronine (fT3), and free thyroxine (fT4) are crucial for accurate diagnosis. This study establishes these intervals from birth to 18 years, noting significant age-related declines and sex differences in fT3.

Area of Science:

  • Endocrinology
  • Pediatric Endocrinology
  • Clinical Chemistry

Background:

  • Accurate interpretation of pediatric thyroid hormone measurements requires age- and sex-specific reference intervals.
  • Limited data exists for pediatric reference values of TSH, fT3, and fT4.
  • Reference intervals are known to be method- and population-dependent.

Purpose of the Study:

  • To establish reference intervals for serum TSH, fT3, and fT4 in children from birth to 18 years.
  • To assess potential sex differences in these thyroid hormone levels.
  • To provide updated reference data considering analytical methods and population variations.

Main Methods:

  • Retrospective analysis of 2,194 thyroid hormone tests from a pediatric population.
  • Exclusion of individuals with conditions or medications affecting thyroid function.
  • Measurement of fT3, fT4, and TSH using the Advia(R) Centaur automated immunoassay system.

Main Results:

  • Final sample sizes: 1,209 for TSH, 1,395 for fT3, and 1,229 for fT4.
  • Median concentrations of fT3, fT4, and TSH were highest in the first month of life, declining with age.
  • Males exhibited significantly greater mean fT3 concentrations than females (p < 0.001), with no sex differences found for TSH and fT4.

Conclusions:

  • Thyroid hormone levels change significantly during childhood, rendering adult reference intervals inapplicable.
  • Established reference intervals differ from previous studies, potentially due to analytical methods, population characteristics, or geographic factors.
  • These findings underscore the importance of age- and sex-specific reference intervals for pediatric thyroid hormone assessment.
Abstract

Related Concept Videos

Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...